Uncategorized

Latest Issue of OR Manager
April 2024
Home Uncategorized

Study finds high rates of infection after colonoscopy, OGD performed in ASCs

Editor's Note Rates of infection after colonoscopies and osophagogastroduodenoscopies (OGDs) performed in ambulatory surgery centers (ASCs) are higher than previously thought and vary widely by facility, this study from Johns Hopkins finds. Rates of postendoscopic infection per 1,000 procedures within 7 days were: 1.1 for screening colonoscopy 1.6 for nonscreening…

Read More

By: Judy Mathias
June 4, 2018
Share

Budget deal includes big changes for healthcare

Editor's Note The US Congress on February 9 passed a budget deal that will have a significant impact across nearly every sector of the healthcare industry, the March 9 Business Insider reports. Among the initiatives are: $2 billion for the National Institutes of Health $6 billion to combat the opioid…

Read More

By: Judy Mathias
February 9, 2018
Share

FDA clears updated design, labeling for Pentax duodenoscope

Editor's Note The Food and Drug Administration (FDA) on February 7 announced that it had cleared the updated design and labeling for Pentax Medical's duodenoscope Model ED-3490TK. Pentax replaced the forceps elevator mechanism, O-ring seal, and distal end cap, and updated the Operation Manual to recommend annual maintenance. The design…

Read More

By: Judy Mathias
February 7, 2018
Share

NSQIP: Effect of modifications to OR attire on SSIs

Editor's Note Implementation of stringent OR attire policies that include full coverage of ears and facial hair do not reduce surgical site infection (SSI) rates, finds this study. Researchers compared National Surgical Quality Improvement Program (NSQIP) data from all patients having surgery 9 months before implementation (3,077) to 3,440 patients…

Read More

By: Judy Mathias
February 5, 2018
Share

Sponsored Message

Top 10 health technology hazards for 2018 named

Medical technology is intended to improve patient care, but even the best technology—if configured, used, or maintained improperly—can lead to problems. Hospitals must regularly examine their hazard control priorities to target the most pressing risks. ECRI Institute’s annual Top 10 Health Technology Hazards report identifies high-priority sources of danger or…

Read More

By: OR Manager
January 19, 2018
Share

ASC quality reporting deadlines moved up in 2018

On November 1, 2017, the Centers for Medicare & Medicaid Services (CMS) released its final rule for the 2018 Medicare Hospital Outpatient Prospective Payment System/ASC Payment System and Quality Reporting Programs. In summary, several ambulatory surgery center (ASC) measures (ASC-1 to ASC-14) are unaffected, except that three measures (ASC-5, -6,…

Read More

By: Leslie Flowers
December 14, 2017
Share

Sponsored Message

ECRI Institute issues annual technology hazards list

Editor's Note ECRI Institute on December 12 issued its list of Top 10 Health Technology Hazards for 2018. The list, which is available for free (registration required), identifies sources of technology dangers or difficulties and details steps to minimize the occurrence of adverse events. Topping the list is ransomware and…

Read More

By: Judy Mathias
December 12, 2017
Share

FDA clears first duodenoscope with disposable end cap

Editor's Note The Food and Drug Administration (FDA) on September 20 cleared the first duodenoscope with a disposable end cap, which will improve access for cleaning and reprocessing. The new features of the Pentax ED34-i10T duodenoscope include a single-use detachable and disposable distal cap, simpler user interface, improved ergonomics, improved…

Read More

By: Judy Mathias
September 21, 2017
Share

FDA: All ED-530XT duodenoscopes by Fujifilm recalled

Editor's Note The Food and Drug Administration (FDA) on July 21 announced the recall by Fujifilm of its ED-530XT duodenoscopes. The recall includes replacement of the ED-530XT forceps elevator mechanism including the o-ring seal, replacement of the distal end cap, and a new operations manual. The FDA cleared the updated…

Read More

By: Judy Mathias
July 31, 2017
Share

New combination of tests identify patients with benign pancreatic cysts

Editor's Note The combination of two molecular biology tests is the first to distinguish, with near certainty, pancreatic lesions that mimic early signs of cancer but are completely benign, this study finds. The vascular endothelial growth factor-A test alone singled out benign serious cystic neoplasms with a sensitivity of 100%…

Read More

By: Judy Mathias
June 26, 2017
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat